Peripheral nerve stimulation (PNS) is a treatment for chronic pain that uses small electrical currents delivered through thin wires placed near a specific nerve. The electrical signals interrupt pain messages before they reach your brain, reducing how much pain you feel. It’s typically reserved for people whose chronic pain hasn’t improved with medications, physical therapy, or other less invasive treatments.
How It Reduces Pain
The core idea behind PNS comes from a concept called gate control theory. Your nervous system carries two types of signals through different nerve fibers: ordinary touch sensations travel along large, fast fibers, while pain signals travel along smaller, slower ones. When a PNS device sends a mild electrical current to the large fibers, it essentially activates a “gate” at the spinal cord that blocks the smaller pain fibers from transmitting their signals upward to the brain. The result is that pain messages get dampened or shut out before you ever consciously feel them.
The full picture is more complex than a single gate. Research suggests PNS also works by reducing the excitability of pain-sensing nerve fibers themselves, depleting certain chemicals that amplify pain signaling, and boosting the release of natural inhibitory substances in the spinal cord. Repeated electrical stimulation can cause pain fibers to “fatigue,” making them less likely to fire. Both peripheral effects (changing how nerves conduct signals) and central effects (altering brain and spinal cord activity) appear to contribute to pain relief.
Conditions It Treats
PNS targets neuropathic pain, the type caused by damaged or dysfunctional nerves rather than by ongoing tissue injury. It works best when pain follows a specific nerve’s territory, meaning your doctor can trace the pain to a particular nerve pathway. Common conditions include:
- Occipital neuralgia: chronic headaches originating from nerves at the base of the skull
- Post-amputation pain: phantom limb or residual limb pain after surgery
- Nerve injuries in the arms or legs: damage to the median, ulnar, radial, femoral, or sciatic nerves
- Meralgia paresthetica: burning or numbness on the outer thigh from a compressed nerve
- Intercostal neuralgia: pain along the rib cage from damaged nerves between the ribs
- Lumbar or cervical radiculitis: irritated spinal nerve roots causing radiating pain
- Pudendal neuralgia: pelvic pain from the pudendal nerve
How PNS Differs From Spinal Cord Stimulation
PNS and spinal cord stimulation (SCS) both use electrical signals to manage pain, but they target different locations. SCS places leads in the epidural space right next to the spinal cord, aiming to intercept pain signals centrally before they travel up to the brain. PNS, by contrast, places leads directly alongside a specific peripheral nerve, far from the spine. This makes PNS more targeted: instead of broadly modulating spinal cord activity, it addresses the exact nerve responsible for your pain. For people whose pain clearly follows one nerve’s pathway, PNS can be a more precise option.
What the Hardware Looks Like
A PNS system has two main components: a thin electrode lead and a pulse generator that powers it. The lead is a flexible wire with 8 to 16 contact points that sits alongside the target nerve. In traditional systems, this lead connects to an implantable pulse generator roughly the size of a stopwatch, placed under the skin in the abdomen, chest wall, buttock, or thigh.
Newer wireless systems have changed the setup considerably. Instead of an implanted battery, a tiny lead is inserted next to the nerve through a needle under ultrasound guidance. An external pulse generator worn in a belt, fabric sleeve, or similar wearable transmits power wirelessly to the implanted lead. This eliminates the need for a second surgical pocket for the battery, reduces the invasiveness of the procedure, and lowers the risk of complications from tunneling wires under the skin. Some temporary systems are FDA-approved for short-term use of up to 60 days, though they carry some infection risk from leads that exit through the skin.
The Trial Phase and Implantation
Before committing to a permanent device, you go through a trial period lasting about a week. During this trial, thin leads are placed near the target nerve using a needle, and the wires connect to an external stimulator secured to your body. The placement procedure takes 30 to 90 minutes and is done in a clinic or day surgery center. You go home the same day and live with the device for several days, keeping track of your pain levels and how well the stimulation works during normal activities.
If the trial provides meaningful relief, you move forward with a permanent implant. This is a surgical procedure performed in an operating room. The leads are positioned at the pain source, and a small incision is made to place the pulse generator under your skin. Patients are typically discharged the same day. Expect two to three weeks of healing before gradually returning to full activity.
Who Qualifies for PNS
PNS is not a first-line treatment. Consensus guidelines from the American Society of Pain and Neuroscience specify that candidates should have chronic, intractable pain from a condition known to respond to nerve stimulation, and they should have already tried and failed to improve with conservative treatments. That means adequate attempts at medication management, physical therapy, psychological therapy, and less invasive procedures before PNS is considered. Insurance coverage generally follows the same requirement: documented failure of conservative care.
How Well It Works
Clinical data on PNS efficacy is encouraging, particularly for specific pain conditions. In a randomized controlled trial of 28 lower-extremity amputees with post-amputation pain, 58% of those receiving PNS reported at least a 50% reduction in pain after four weeks, compared to 14% receiving a placebo. Another randomized trial of 89 participants found that 84% of patients receiving PNS combined with standard medical care responded to treatment at three months, versus just 3% of those on standard care alone.
Longer-term data is also positive. Studies examining patients over 3 to 16 years of PNS use found that 62% to 78% of people with severe chronic neuropathic pain reported sustained pain relief. These numbers are notable for a population that, by definition, had already failed other treatments.
Risks and Complications
An analysis of over 1,100 complication reports found that procedural complications were the most common category (31.3%), followed closely by device-related problems (30.9%) and patient complaints (24%). Infection was the single most frequently reported procedural complication, accounting for 26.8% of all procedural issues. This rate was higher than previously expected, highlighting the importance of careful patient selection and sterile technique during placement.
Among device-related complications, lead migration was the most common at 10.5%, meaning the electrode shifted from its original position and stimulation became less effective or missed the target nerve. Erosion of device components through the skin occurred in about 8% of device-related reports, and electrical shock was reported in roughly 4.5%. When complications did arise, device removal was the most common solution (46.3% of cases), while others were managed with surgical revision (17.7%) or nonsurgical approaches (22.9%).
These numbers represent reported adverse events rather than overall complication rates across all PNS patients, so the actual per-patient risk is lower than these percentages might suggest. Still, infection and lead migration are the two issues worth discussing with your doctor before proceeding.